Work

PP01.50 SAFFRON: Savolitinib + Osimertinib vs Chemotherapy in EGFRm NSCLC with MET Overexpression/Amplification Post-Osimertinib

Year: 2024

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2024.05.287

Authors: Zofia Piotrowska, Wanning Xu, Aino Telaranta-Keerie, Nan Jia, Ryan Hartmaier, Shun Lu

Institutions: Massachusetts General Hospital, AstraZeneca (United Kingdom), AstraZeneca (United States), Shanghai Jiao Tong University, Shanghai Chest Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4400452770

Cites:

Cited by: 6

Related to: 10